Who Qualifies for Ozempic in Europe? A Patient's Guide

Key Point 1 Ozempic is primarily approved in Europe for managing type 2 diabetes and, in some cases, for weight management in individuals with obesity or who are overweight with related health conditions.

Key Point 2 Eligibility typically involves a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with weight-related comorbidities such as hypertension, dyslipidemia, or sleep apnea.

Key Point 3 A comprehensive medical evaluation by an EU-licensed doctor is essential to determine if Ozempic is appropriate, considering individual health history and potential risks.

Key Point 4 Hi Doctor AI offers a convenient way to consult with EU-licensed doctors online to assess your eligibility for Ozempic and receive a valid prescription if appropriate.

Understanding Ozempic and Its Uses

Ozempic is a prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It was initially developed to improve blood sugar control in adults with type 2 diabetes. Semaglutide works by mimicking the effects of the natural GLP-1 hormone, which helps to lower blood sugar levels by stimulating insulin release when glucose levels are high, inhibiting glucagon secretion, and slowing gastric emptying.

In addition to its use in diabetes management, Ozempic has also been shown to be effective for weight loss. Clinical trials have demonstrated that individuals taking semaglutide can achieve significant reductions in body weight, making it a valuable option for people struggling with obesity or overweight with related health conditions. Because of this dual benefit, Ozempic is sometimes prescribed off-label for weight management, even in individuals without diabetes but who meet specific criteria related to their weight and overall health.

Who is Eligible for Ozempic in Europe?

In Europe, the eligibility criteria for Ozempic are primarily based on its approved uses and relevant guidelines. The primary conditions that qualify individuals for an Ozempic prescription include:

• Type 2 Diabetes: Ozempic is approved for adults with type 2 diabetes to improve glycemic control. It is often used in conjunction with diet and exercise, and sometimes with other diabetes medications.
• Obesity or Overweight with Comorbidities: Ozempic may be considered for individuals who are obese (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) and have at least one weight-related comorbidity, such as hypertension, dyslipidemia (abnormal cholesterol levels), sleep apnea, or cardiovascular disease.

It’s important to note that the decision to prescribe Ozempic is made on a case-by-case basis by a healthcare professional, taking into account the individual's medical history, current health status, and potential risks and benefits of the medication. A thorough medical evaluation is necessary to determine if Ozempic is appropriate.

BMI and Other Health Requirements

Body Mass Index (BMI) is a key factor in determining eligibility for Ozempic, particularly when it is being considered for weight management. As mentioned earlier, a BMI of 30 kg/m² or higher generally indicates obesity, while a BMI of 27 kg/m² or higher with at least one weight-related comorbidity may also qualify an individual. However, BMI is not the only factor.

Other health requirements and considerations include:

• Absence of Contraindications: Individuals with certain medical conditions may not be suitable candidates for Ozempic. Contraindications can include a history of pancreatitis, gallbladder disease, or certain types of thyroid cancer.
• Overall Cardiovascular Health: Given that Ozempic can affect heart rate and blood pressure, individuals with pre-existing cardiovascular conditions require careful evaluation.
• Kidney and Liver Function: Impaired kidney or liver function may affect how Ozempic is metabolized and cleared from the body, potentially requiring dosage adjustments or making the medication unsuitable.
• Other Medications: A review of current medications is essential to avoid potential drug interactions. For example, Ozempic can interact with other diabetes medications, potentially leading to hypoglycemia (low blood sugar).

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and efficient way to determine your eligibility for Ozempic and receive a prescription if appropriate. Our platform connects you with EU-licensed doctors who can conduct a thorough online consultation, assess your medical history, and evaluate whether Ozempic is a suitable treatment option for you.

The process is simple:

1. Online Consultation: Fill out a detailed medical questionnaire on our secure platform. This questionnaire covers your medical history, current health status, and any medications you are currently taking. No video call is required.
2. Doctor Review: An EU-licensed doctor reviews your information to determine if Ozempic is appropriate for you. They consider your BMI, any existing health conditions, and potential contraindications.
3. Prescription: If the doctor determines that Ozempic is a safe and suitable option, they will issue a valid EU prescription. You can then use this prescription at any licensed pharmacy in the EU to obtain your medication.

Hi Doctor AI provides a convenient alternative to traditional in-person doctor visits, saving you time and offering a discreet way to access medical care. The consultation fee is 25€, and you will receive a full refund if a prescription is not issued.

Ready to Get Started?

Ready to start your weight loss journey? Get your online consultation with Hi Doctor AI—EU-licensed doctors, 25€ consultation fee, prescriptions in under 24 hours.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.